Retour
Fourchette du Jour
8,84 €
9,31 €
Fourchette 52 Semaines
4,32 €
13,71 €
Volume
543 662
Moyenne 50J / 200J
9,16 €
/
8,69 €
Clôture Précédente
8,73 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,1 | 0,2 |
| P/B | 1,8 | 3,0 |
| ROE % | -63,6 | 3,6 |
| Net Margin % | -2520,6 | 3,8 |
| Rev Growth 5Y % | -53,1 | 9,9 |
| D/E | 0,1 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue declined -53,12% annually over 5 years
Debt/Equity of 0,05 — conservative balance sheet
Negative free cash flow of -163,72M
Revenue growth is decelerating — 1Y growth trails 5Y average by 39,71%
Capital efficient — spends only 1,43% of revenue on capex
Croissance
Revenue Growth (5Y)
-53,12%
Revenue (1Y)-92,83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-63,62%
ROIC-47,03%
Net Margin-2520,57%
Op. Margin-1905,82%
Sécurité
Debt / Equity
0,05
Current Ratio7,72
Interest Coverage0,00
Valorisation
P/E Ratio
-2,05
Forward P/EN/A
P/B Ratio1,79
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -92,83% | Revenue Growth (3Y) | -67,44% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -53,12% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9,68M | Net Income (TTM) | -244,09M |
| ROE | -63,62% | ROA | -74,69% |
| Gross Margin | 61,77% | Operating Margin | -1905,82% |
| Net Margin | -2520,57% | Free Cash Flow (TTM) | -163,72M |
| ROIC | -47,03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 7,72 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,05 | Forward P/E | N/A |
| P/B Ratio | 1,79 | P/S Ratio | 51,75 |
| PEG Ratio | -0,02 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -32,67% | ||
| Market Cap | 501,19M | Enterprise Value | 207,51M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9,68M | 135,16M | 91,37M | 53,91M | 200,58M |
| Net Income | -244,09M | -122,31M | -147,03M | -116,95M | 66,98M |
| EPS (Diluted) | -4,53 | -2,27 | -2,76 | -2,47 | 1,38 |
| Gross Profit | 5,98M | 135,16M | 91,37M | 53,91M | 200,58M |
| Operating Income | -184,56M | -154,56M | -191,04M | -131,56M | 71,98M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 326,80M | 547,11M | 696,38M | 758,04M | 609,37M |
| Total Liabilities | 46,33M | 60,18M | 135,02M | 135,99M | 143,32M |
| Shareholders' Equity | 280,47M | 486,93M | 561,37M | 622,04M | 466,04M |
| Total Debt | 13,86M | 10,84M | 11,84M | 6,47M | 12,33M |
| Cash & Equivalents | 307,53M | 471,39M | 618,83M | 710,41M | 579,09M |
| Current Assets | 315,19M | 485,41M | 639,28M | 719,10M | 584,81M |
| Current Liabilities | 40,84M | 48,50M | 56,89M | 50,15M | 33,45M |